These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
    Author: Carlone NA, Cuffini AM, Forno-Pizzoglio M, Aragno M.
    Journal: G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297.
    Abstract:
    Dibekacin is a semisynthetic aminonglycoside derivative of kanamicin B, with highly activity against most gram-positive and gramnegative bacteria. It is also active against bacteria relatively resistant to other antibiotics. Since Pseudomonas aeruginosa seems to be the most common strain recent clinical isolated, we compared the in vitro activity of dibekacin with other eigh cephalosporins against 579 clinical isolates of sensitive and gentamicin-carbenicillin resistant Pseudomonas aeruginosa. The results indicate that dibekacin was more active than any of the other antibiotics tested against all the organisms tested, including carbenicillin-resistant Pseudomonas aeruginosa.
    [Abstract] [Full Text] [Related] [New Search]